pharma · Systemic Sclerosis · Nonalcoholic Steatohepatitis · CMMB
Chemomab Therapeutics
Chemomab Therapeutics trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.
Tel Aviv, USA HQ
2011 Founded
20 Employees
Public company Type
CMMB · NYSE Ticker
Company details
- Status
- Public
- HQ
- Tel Aviv, USA
- Founded
- 2011
- Employees
- 20
- Programs
- 6
- Drugs
- 4
- Patents
- 4
Chemomab Therapeutics clinical trials
Registry index of 6 ClinicalTrials.gov studies linked to Chemomab Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Chemomab Therapeutics trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Chemomab Therapeutics.
-
Anti-human CCL24 monoclonal antibody (CM-101) — Phase 2
Clinical update -
Anti-human CCL24 monoclonal antibody (CM-101) - Part One — Phase 1
Clinical update -
Anti-human CCL24 monoclonal antibody (CM-101) — Phase 1
Clinical update -
CM-101 — Phase 1
Clinical update -
5 mg/kg CM-101 — Phase 2
Clinical update -
10 mg/kg CM-101 — Phase 2
Clinical update
Trial registry
-
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ - NCT06044467CT.gov ↗
Anti-human CCL24 monoclonal antibody (CM-101) - Part One
Nonalcoholic Fatty Liver Disease
-
CT.gov ↗